DRUGSCAN, in partnership with ACM Global Laboratories, is proud to announce that we are now offering COVID-19 testing as part of ViraScan—our new viral testing service.
As a SAMHSA-certified, high complexity laboratory with CAP accreditation, DRUGSCAN is a recognized leader in toxicology testing, and now, at the forefront of diagnostic efforts for SARS-CoV-2. Testing is only one critical step in mitigating the spread of COVID-19 — time is of the essence. That’s why we consistently deliver test results in 48 hours or less after receiving a specimen.
DRUGSCANs’ test uses the Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) to detect the SARS-CoV-2 virus, and is the most widely used, and accurate method for identification of acute infections. The test itself is performed using a sample collected from a patient by nasopharyngeal or nasal swab from which we can identify the presence of COVID-19’s genetic material, or viral RNA which will be present in the body before antibodies form or symptoms of the disease are present. And with early detection, we can help keep more people safe from infection.
“Like everyone, we are following the world events closely, and recognize that we have a unique capability to address the current shortage of COVID-19 testing,” said Anthony G. Costantino, PhD, F-ABFT. “We have a modern, state-of-the-art lab and trained staff already in place, so adding this much-needed service was an easy decision. We are committed to do our part in the fight against this virus.”
Now there’s even more reason to partner with DRUGSCAN:
To learn more about our COVID-19 testing with ViraScan viral testing services, contact us.
DRUGSCAN is part of ACM Global Laboratories, an affiliate of Rochester Regional Health, and one of the largest global independent central labs in the industry. ACM is certified by the College of American Pathologists (CAP) and the Substance Abuse and Mental Health Services Administration (SAMHSA). The company delivers high-quality laboratory testing and diagnostic lab services in support of both clinical trials research, toxicology and individual patient care.
ACM provides a powerful combination of operational excellence, scientific expertise and unsurpassed global service to customers in more than 65 countries. ACM performs more than 30 million laboratory tests each year—spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more.